| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.023 | 0.4 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |